Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
3(100.0%)
3Total
Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01293045Phase 1Completed

Biological Bone Markers and Hydrolyzed Collagen Supplement in Menopausal Healthy Women

Role: lead

NCT01897662Phase 1Completed

Effect of Nutriose Supplementation on Satiety, Weight Loss and Adiposity in Overweight Subjects

Role: lead

NCT01897649Phase 1Completed

Effect of 15g Daily Consumption of NUTRIOSE on Healthy Volunteers Microbiota.

Role: lead

All 3 trials loaded